Lv4
520 积分 2024-05-09 加入
Diagnostic Performance of Commercial Antithrombin Activity Assays: Do We Get What We Expect?
22天前
已完结
The Laboratory Monitoring of Altuvoct (Efanesoctocog Alfa): Recommendations From the Laboratory Working Party of the United Kingdom Haemophilia Centres Doctor's Organisation
3个月前
已完结
Chromogenic Factor VIII Assay for Patients with Hemophilia A and on Emicizumab Therapy
4个月前
已完结
International Council for Standardization in Haematology recommendations for laboratory measurement of factorVIIIandFIXtypeIinhibitors
4个月前
已完结
Chromogenic Factor VIII Assay for Patients with Hemophilia A and on Emicizumab Therapy
4个月前
已完结
Verification and Implementation of a Bovine Chromogenic Factor VIII Assay for Hemophilia A Patients on Emicizumab Therapy
4个月前
已完结
Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumab
4个月前
已关闭
Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients
5个月前
已完结
Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers
5个月前
已完结
Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A
5个月前
已完结
皖公网安备34019202002308
